An evidence-based approach to the post-marketing withdrawal of medicinal products because of adverse reactions

Slični predmeti

• Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database
  od: Stefania Chiappini, i dr.
  Izdano: (2020-02-01)
• Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.
  od: Onakpoya, I, i dr.
  Izdano: (2016)
• The withdrawal of drugs from the market as a result of post-authorisation pharmacovigilance
  od: Łukasz Dobrek
  Izdano: (2022-08-01)
• Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
  od: Onakpoya, IJ, i dr.
  Izdano: (2016)
• Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
  od: Igho J. Onakpoya, i dr.
  Izdano: (2019-03-01)